Navidea Biopharmaceuticals IncNavidea Biopharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This dashboard includes a questions and answers table on Navidea Biopharmaceuticals Inc. If you are employed by Navidea Biopharmaceuticals Inc and you would like to licence your ESG rating, please get in touch. This ESG score for Navidea Biopharmaceuticals Inc indicates its transparency towards the UN Sustainable Development Goals.

Navidea Biopharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.5; made up of an environmental score of 5.3, social score of 3.2 and governance score of 8.0.

SDG Transparency Score for Navidea Biopharmaceuticals Inc 
Low
0 - 3

5.5

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Navidea Biopharmaceuticals Inc 
5.3

Environmental

3.2

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
602SkinBioTherapeutics PLC
5.6
High
602XOMA Corp
5.6
High
627Navidea Biopharmaceuticals Inc
5.5
High
627Advanced Medical Solutions Group PLC
5.5
High
627Achieve Life Sciences Inc
5.5
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Navidea Biopharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Navidea Biopharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Navidea Biopharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Navidea Biopharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Navidea Biopharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Navidea Biopharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Navidea Biopharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission computed tomography, positron emission tomography (PET), gamma-scanning, and intra-operative and/or optical-fluorescence detection, as well as delivery of therapeutic compounds that target macrophages, and immune-and inflammation-involved diseases. It develops NAV3-31, which has completed Phase IIb clinical trials for evaluating imaging repeatability, reproducibility, and stability, as well as the capacity of Tc99m tilmanocept imaging for treatment of anti-tumor necrosis factor alpha therapy in patients with moderate to severe rheumatoid arthritis (RA); NAV3-35 that is in a Phase IIb clinical trial for RA imaging; NAV3-33, which is in Phase III clinical trial for RA; and NAV3-32, which is Phase 2b trial for RA-involved joints. The company is also developing Tc99m tilmanocept for cardiovascular, kaposi's sarcoma, tuberculosis, and other immunotherapeutic applications. The company was formerly known as Neoprobe Corporation and changed its name to Navidea Biopharmaceuticals, Inc. in January 2012. Navidea Biopharmaceuticals, Inc. was incorporated in 1983 and is headquartered in Dublin, Ohio.

Sorry!

Failed to process!